Waters launches XBridge Premier GTx BEH SEC columns for gene therapy applications

FHS
August 24, 2023
10:21 am

Waters Corporation introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors.

Big drugmakers have cut outside R&D spending amid broad pullback, key contractor warns

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 8, 2024

After decades of anti-vaccine rhetoric, RFK Jr. pivots to chronic diseases — and gets Trump on board

WASHINGTON — Last month, before he called it quits on a presidential run, Robert F. Kennedy Jr., ran social media ads asking, “Is America sicker

August 30, 2024

New Study Links Depression to Higher Body Temperature Using Oura Rings

What You Should Know: A new study led by researchers at the University of California San Diego and the University of California San Francisco suggests

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.